{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:25:03Z","timestamp":1776119103088,"version":"3.50.1"},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2021,7,15]]},"DOI":"10.18632\/aging.203244","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T21:29:19Z","timestamp":1625693359000},"page":"17536-17547","source":"Crossref","is-referenced-by-count":2,"title":["IGF IIR\u03b1-triggered pathological manifestations in the heart aggravate renal inflammation in STZ-induced type-I diabetes rats"],"prefix":"10.18632","volume":"13","author":[{"given":"Henry Cherng-Han","family":"Lin","sequence":"first","affiliation":[{"name":"Graduate Institute of Chinese Medicine, China Medical University, Taichung 404, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine Reena","family":"Paul","sequence":"additional","affiliation":[{"name":"Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Hua","family":"Kuo","sequence":"additional","affiliation":[{"name":"Laboratory of Exercise Biochemistry, University of Taipei, Taipei 11153, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Hsien","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Chinese Medicine, China Medical University Hospital, China Medical University, Taichung 404, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William Shao-Tsu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Tzu Chi General Hospital, Hualien 97004, Taiwan"},{"name":"School of Medicine, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Jung","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Chinese Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 97004, Taiwan"},{"name":"Integration Center of Traditional Chinese and Modern Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"},{"name":"School of Post-Baccalaureate Chinese Medicine, College of Medicine, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia Hsuan","family":"Day","sequence":"additional","affiliation":[{"name":"Department of Nursing, MeiHo University, Pingtung 912, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijaya Padma","family":"Viswanadha","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Bharathiar University, Coimbatore 641046, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhsin","family":"Tsai","sequence":"additional","affiliation":[{"name":"Graduate Institute of Chinese Medicine, China Medical University, Taichung 41354, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Yang","family":"Huang","sequence":"additional","affiliation":[{"name":"Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"},{"name":"Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404, Taiwan"},{"name":"Center of General Education, Buddhist Tzu Chi Medical Foundation, Tzu Chi University of Science and Technology, Hualien 970, Taiwan"},{"name":"Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan"},{"name":"Department of Biotechnology, Asia University, Taichung 413, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"e0187670","DOI":"10.1371\/journal.pone.0187670","article-title":"Increasing prevalence of diabetes mellitus in a developing country and its related factors.","volume":"1","author":"Seyoum","year":"2017","journal-title":"PLoS One"},{"key":"2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.hjc.2017.01.003","article-title":"Diabetes and cardiorenal syndrome: Understanding the \u201cTriple Threat\u201d.","volume":"5","author":"Panas","year":"2017","journal-title":"Hellenic J Cardiol"},{"key":"3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jacc.2012.01.077","article-title":"Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.","volume":"6","author":"McCullough","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ihj.2017.01.005","article-title":"Pathophysiology of the cardio-renal syndromes types 1-5: An uptodate.","volume":"6","author":"Ronco","year":"2017","journal-title":"Indian Heart J"},{"key":"5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/s1885-5857(10)70041-4","article-title":"Prevalence of chronic kidney disease in patients with or at a high risk of cardiovascular disease.","volume":"6","author":"Garrido Costa","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"6","first-page":"e71","article-title":"Harnessing fetal and adult genetic reprograming for therapy of heart disease.","volume":"1","author":"Mishra","year":"2015","journal-title":"J Nat Sci"},{"key":"7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/pr.2017.18","article-title":"Fetal origins of adult cardiac disease: a novel approach to prevent fetal growth restriction induced cardiac dysfunction using insulin like growth factor.","volume":"8","author":"Habli","year":"2017","journal-title":"Pediatr Res"},{"key":"8","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/j.bbadis.2013.07.023","article-title":"Regulation of fetal gene expression in heart failure.","volume":"183","author":"De Windt","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ijcard.2017.10.102","article-title":"Inhibition of HSF2 SUMOylation via MEL18 upregulates IGF-IIR and leads to hypertension-induced cardiac hypertrophy.","volume":"25","author":"Huang","year":"2018","journal-title":"Int J Cardiol"},{"key":"10","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1002\/jcp.29242","article-title":"The combined inhibition of the CaMKII\u03b4 and calcineurin signaling cascade attenuates IGF-IIR-induced cardiac hypertrophy.","volume":"23","author":"Huang","year":"2020","journal-title":"J Cell Physiol"},{"key":"11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1677\/JOE-07-0619","article-title":"IGF-II\/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide\/BNP expression via Galphaq interaction and protein kinase C-alpha\/CaMKII activation in H9c2 cardiomyoblast cells.","volume":"19","author":"Huang","year":"2008","journal-title":"J Endocrinol"},{"key":"12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1677\/JME-08-0051","article-title":"IGF-II\/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.","volume":"4","author":"Chu","year":"2008","journal-title":"J Mol Endocrinol"},{"key":"13","doi-asserted-by":"publisher","first-page":"e2455","DOI":"10.1038\/cddis.2016.356","article-title":"Doxorubicin attenuates CHIP-guarded HSF1 nuclear translocation and protein stability to trigger IGF-IIR-dependent cardiomyocyte death.","volume":"7","author":"Huang","year":"2016","journal-title":"Cell Death Dis"},{"key":"14","doi-asserted-by":"publisher","first-page":"C235","DOI":"10.1152\/ajpcell.00079.2019","article-title":"Insulin-like growth factor II receptor-\u03b1 is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.","volume":"31","author":"Huang","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"15","doi-asserted-by":"publisher","first-page":"16956","DOI":"10.1002\/jcb.28957","article-title":"Upregulation of IGF-IIR\u03b1 intensifies doxorubicin-induced cardiac damage.","volume":"12","author":"Huang","year":"2019","journal-title":"J Cell Biochem"},{"key":"16","doi-asserted-by":"publisher","first-page":"e0216285","DOI":"10.1371\/journal.pone.0216285","article-title":"Synergistic cardiac pathological hypertrophy induced by high-salt diet in IGF-IIR\u03b1 cardiac-specific transgenic rats.","volume":"1","author":"Huang","year":"2019","journal-title":"PLoS One"},{"key":"17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/tox.22676","article-title":"Overexpression of IGF-IIR\u03b1 regulates cardiac remodeling and aggravates high salt induced apoptosis and fibrosis in transgenic rats.","volume":"3","author":"Huang","year":"2019","journal-title":"Environ Toxicol"},{"key":"18","unstructured":"The diagnosis of diabetes. Installment 5: identifying the diabetes suspect. Diabetic neuropathy, nephropathy and vascular disease as presenting findings. The pregnant patient. GP. 1969; 39:133-55."},{"key":"19","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1161\/01.hyp.31.6.1255","article-title":"Interactive nitric oxide-angiotensin II influences on renal microcirculation in angiotensin II-induced hypertension.","volume":"3","author":"Navar","year":"1998","journal-title":"Hypertension"},{"key":"20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/jama.2015.0602","article-title":"Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review.","volume":"31","author":"Inker","year":"2015","journal-title":"JAMA"},{"key":"21","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41419-019-2085-0","article-title":"Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice.","volume":"1","author":"Wang","year":"2019","journal-title":"Cell Death Dis"},{"key":"22","doi-asserted-by":"publisher","first-page":"F1151","DOI":"10.1152\/ajprenal.00034.2019","article-title":"Targeting STAT3 signaling in kidney disease.","volume":"31","author":"Mallipattu","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"23","doi-asserted-by":"publisher","first-page":"F762","DOI":"10.1152\/ajprenal.00181.2005","article-title":"Role of the JAK\/STAT signaling pathway in diabetic nephropathy.","volume":"29","author":"Eaton","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"24","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1016\/j.febslet.2008.09.014","article-title":"Suppressor of cytokine signaling-1 reduces high glucose-induced TGF-beta1 and fibronectin synthesis in human mesangial cells.","volume":"58","author":"Duan","year":"2008","journal-title":"FEBS Lett"},{"key":"25","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.2337\/diabetes.51.12.3505","article-title":"Inhibition of the Jak\/STAT signaling pathway prevents the high glucose-induced increase in tgf-beta and fibronectin synthesis in mesangial cells.","volume":"5","author":"Marrero","year":"2002","journal-title":"Diabetes"},{"key":"26","doi-asserted-by":"publisher","first-page":"16925","DOI":"10.18632\/oncotarget.14808","article-title":"Activation of PI3K in response to high glucose leads to regulation of SOCS-3 and STAT1\/3 signals and induction of glomerular mesangial extracellular matrix formation.","volume":"8","author":"Chiang","year":"2017","journal-title":"Oncotarget"},{"key":"27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jss.2012.06.050","article-title":"The role of the Janus kinase family\/signal transducer and activator of transcription signaling pathway in fibrotic renal disease.","volume":"17","author":"Meldrum","year":"2012","journal-title":"J Surg Res"},{"key":"28","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.7150\/thno.32352","article-title":"Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation.","volume":"9","author":"Zhao","year":"2019","journal-title":"Theranostics"},{"key":"29","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ki.2011.223","article-title":"Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).","volume":"8","author":"Ritz","year":"2011","journal-title":"Kidney Int"},{"key":"30","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1093\/ndt\/14.9.2178","article-title":"Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease.","volume":"1","author":"London","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000479010","article-title":"Elevated Phosphate Levels Trigger Autophagy-Mediated Cellular Apoptosis in H9c2 Cardiomyoblasts.","volume":"8","author":"Huang","year":"2017","journal-title":"Cardiorenal Med"},{"key":"32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000371454","article-title":"Hyperphosphate-Induced Myocardial Hypertrophy through the GATA-4\/NFAT-3 Signaling Pathway Is Attenuated by ERK Inhibitor Treatment.","volume":"5","author":"Wang","year":"2015","journal-title":"Cardiorenal Med"},{"key":"33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2310\/JIM.0b013e318250b101","article-title":"Angiotensin II-mediated left ventricular abnormalities in chronic kidney disease.","volume":"6","author":"Skipper","year":"2012","journal-title":"J Investig Med"},{"key":"34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.22088\/cjim.10.1.36","article-title":"The relationship between Aldosterone level and various LV conditions in patients with End-stage renal disease.","volume":"1","author":"Jalalian","year":"2019","journal-title":"Caspian J Intern Med"},{"key":"35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000100106","article-title":"Role of aldosterone in left ventricular hypertrophy among African-American patients with end-stage renal disease on hemodialysis.","volume":"2","author":"Provenzano","year":"2007","journal-title":"Am J Nephrol"},{"key":"36","doi-asserted-by":"publisher","first-page":"937398","DOI":"10.1155\/2014\/937398","article-title":"Heart failure in patients with chronic kidney disease: a systematic integrative review.","volume":"201","author":"Covic","year":"2014","journal-title":"Biomed Res Int"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202599","article-title":"Exosome-derived long non-coding RNA ZFAS1 controls cardiac fibrosis in chronic kidney disease.","author":"Sun","year":"2021","journal-title":"Aging (Albany NY)"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T13:00:31Z","timestamp":1628254831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":37,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,7,15]]}},"alternative-id":["203244","34233296"],"URL":"https:\/\/doi.org\/10.18632\/aging.203244","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,7]]}}}